Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	249.86	48.03	13.73
Graham Fair Price	-45.21	66.83	121.97
PEG	696.73	-0.15	0.02
Price/Book	13.16	0.84	0.75
Price/Cash Flow	205.85	-64.26	21.01
Prices/Earnings	284.60	10.91	2.84
Price/Sales	13.46	20.95	18.46
Price/FCF	205.85	-64.26	21.01
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.97	0.83	0.80
Operating Margin	-13.66	0.62	0.71
ROA	-70.13	< 0.005	0.03
ROE	0.07	0.02	-70.58
ROIC	0.04	0.01	-67.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.23	< 0.005	38876.98
Dividends QOQ	0.03	0.22	726.12
EBIT QOQ	-0.18	-0.15	13.42
EPS QOQ	1.46	-0.71	-51.73
FCF QOQ	2.14	-1.36	-36.25
Revenue QOQ	-0.43	-0.02	95.94
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-7492.98	-17667.69	-135.79
Days Sales Outstanding (DSO)	688.05	691.85	0.55
Inventory Turnover	-0.01	< 0.005	57.59
Debt/Capitalization	0.23	0.27	17.29
Quick Ratio	25.54	10.14	-60.28
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	100.23	101.24	1.01
Cash	141.49	31.73	-77.58
Capex	0.00	0.00	0.00
Free Cash Flow	3.56	-1.33	-62.63
Revenue	4.05	4.08	0.74
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	25.54	10.35	-59.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.74	14.06	276.05
Naive Interpretation	Member

06 - Financial Health · Bad

Rating